Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01635049 · ClinicalTrials.gov registry record
Correlating Time-Lapse Parameters Detected by the Eeva™ System With Comprehensive Chromosome Screening Results
A clinical trial, sponsored by Progyny.
- Completed
- Registry status
- 110
- Enrollment target
NCT01635049: Completed study, sponsored by Progyny.
NCT01635049 is a clinical trial that has completed, run by Progyny. The registered enrollment target is 110 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01635049 has completed, sponsored by Progyny.
- COMPLETED
- Registry status
- 110 participants
- Enrollment target
Study Summary
The purpose of this research study protocol is to collect imaging data on embryos followed to blastocyst stage (Day 5-6) and correlate Eeva System parameters with comprehensive chromosome screening (CCS) results, implantation and live birth.
Primary Outcome
Analyse the correlation of time-lapse parameters collected by the Eeva System and comprehensive chromosome screening (CCS) results.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2012-06 |
| Est. Completion | 2014-12 |
What the finished NCT01635049 record still lists
NCT01635049 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01635049 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01635049 about?
NCT01635049 is a clinical study titled "Correlating Time-Lapse Parameters Detected by the Eeva™ System With Comprehensive Chromosome Screening Results". The purpose of this research study protocol is to collect imaging data on embryos followed to blastocyst stage (Day 5-6) and correlate Eeva System parameters with comprehensive chromosome screening (CCS) results, implantation and live birth.
What is the current status of trial NCT01635049?
This trial is currently completed. The enrollment target is 110 participants. The study started on 2012-06. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01635049?
This trial is sponsored by Progyny, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia